Jazz Pharmaceuticals Director Files Form 144 Notice for $664K Sale
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Notice of Proposed Sale ā¢ Company: Jazz Pharmaceuticals plc ($JAZZ) ā¢ Insider: Mary Elizabeth Henderson (Director) ā¢ Proposed Sale: 2,691 Common Shares (~$664,165.71) ā¢ Approx. Price: ~$246.81/share ā¢ Broker: E*TRADE Financial Corporation ā¢ Acquisition Source: Restricted Stock Vesting (09/05/2026)
Comprehensive Analysis
Form 144 Filing Analysis: Jazz Pharmaceuticals plc (JAZZ)
Summary
Director Mary Elizabeth Henderson filed a Form 144 notice of proposed sale covering 2,691 shares of Common Stock with an aggregate market value of $664,165.71 (~$246.81 per share). The proposed sale date is September 8, 2026, executed via E*TRADE Financial Corporation.
Acquisition Details
- Acquisition Date: September 5, 2026
- Nature of Acquisition: Restricted Stock Vesting (Compensation from Issuer)
- Securities Acquired: 2,691 shares
Historical Sales Context (Past 3 Months)
- August 31, 2026: Sold 2,092 shares for gross proceeds of $504,898.00.
Market Impact & Trading Significance
- Trading Significance: Low
- The transaction represents a standard post-vesting disposition of restricted stock.
- With 64,914,577 total shares outstanding, the proposed volume of 2,691 shares (~0.004% of shares outstanding) is immaterial to overall liquidity and unlikely to exert downward market pressure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.